Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage

BACKGROUND: There are limited neuroprotective treatment options for patients with aneurysmal subarachnoid hemorrhage (SAH). Cerebrolysin, a brain-specific proposed pleiotropic neuroprotective agent, has been suggested to improve global functional outcomes in ischemic stroke. We investigated the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Peter Y. M., Ho, Joanna W. K., Ko, Natalie M. W., Li, Ronald P. T., Jian, Leo, Chu, Alberto C. H., Kwan, Marco C. L., Chan, Yung, Wong, Alain K. S., Wong, Hoi-Tung, Chan, Kwong-Yau, Kwok, John C. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607674/
https://www.ncbi.nlm.nih.gov/pubmed/33143640
http://dx.doi.org/10.1186/s12883-020-01908-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607674/
https://www.ncbi.nlm.nih.gov/pubmed/33143640
http://dx.doi.org/10.1186/s12883-020-01908-9

Ejemplares similares